Cargando…
ISS-Ⅲ期伴1q扩增或17p缺失双重打击初诊多发性骨髓瘤患者的预后分析
OBJECTIVE: To evaluate the prognostic significance of combining ISS-Ⅲ and high risk cytogenetic abnormalities [HRCAs, including 1q gain/amplification and del (17p) ] in patients with newly-diagnosed multiple myeloma (NDMM) . METHODS: The clinical characteristics and relevant variables were retrospec...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342365/ https://www.ncbi.nlm.nih.gov/pubmed/31856439 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.11.005 |